REYON
Dead / Abandoned — Abandoned — no statement of use filed (as of 13 Dec 2021)
What this means for you
This application is over — abandoned 13 Dec 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88160759
- Mark type
- Stylized text
- Filed
- 18 Oct 2018
- Published for opposition
- 12 Mar 2019
- Abandoned
- 13 Dec 2021
- Attorney of record
- Corey K. Cho
Goods and services
- Class 005 — Pharmaceuticals: Anaesthetics; Anti-cancer preparations; Anti-inflammatory and antipyretic preparations; Antibiotics; Antihistamines; Antivirals; Cardiovascular pharmaceuticals; Cardiovascular treatment preparations; Diagnostic preparations for medical purposes; Diagnostic reagents and contrast media for medical use; Hormonal preparations; Hormones for medical purposes; Ocular pharmaceuticals; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for use in urology; Pharmaceutical products for treating respiratory diseases; Psychotropics; Therapeutic vaccines; Tumor suppressing agents; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents
Owner
- Reyon Pharmaceutical Co., Ltd, Seoul, KR
- Reyon Pharmaceutical Co., Ltd, Seoul, KR
Prosecution history
- 13 Dec 2021 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 13 Dec 2021 — ABANDONMENT - NO USE STATEMENT FILED
- 07 May 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 May 2021 — SOU EXTENSION 4 GRANTED
- 05 May 2021 — SOU EXTENSION 4 FILED
- 05 May 2021 — SOU TEAS EXTENSION RECEIVED
- 03 Nov 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Oct 2020 — SOU EXTENSION 3 GRANTED
- 30 Oct 2020 — SOU EXTENSION 3 FILED
- 30 Oct 2020 — SOU TEAS EXTENSION RECEIVED
- 14 Apr 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Apr 2020 — SOU EXTENSION 2 GRANTED
- 10 Apr 2020 — SOU EXTENSION 2 FILED
- 10 Apr 2020 — SOU TEAS EXTENSION RECEIVED
- 22 Oct 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED